16.89Open16.89Pre Close0 Volume0 Open Interest96.00Strike Price0.00Turnover3340.28%IV1.41%PremiumDec 27, 2024Expiry Date15.76Intrinsic Value100Multiplier0DDays to Expiry1.13Extrinsic Value100Contract SizeAmericanOptions Type-0.9766Delta0.0078Gamma5.09Leverage Ratio-71.0815Theta0.0000Rho-4.97Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet